Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vistagen Therapeutics (VTGN) Non Operating Income (2025)

Vistagen Therapeutics' Non Operating Income history spans 2 years, with the latest figure at $6000.0 for Q3 2025.

  • For Q3 2025, Non Operating Income changed N/A year-over-year to $6000.0; the TTM value through Dec 2025 reached $4000.0, changed N/A, while the annual FY2021 figure was $600.0, N/A changed from the prior year.
  • Non Operating Income for Q3 2025 was $6000.0 at Vistagen Therapeutics, up from -$2000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $6000.0 in Q3 2025 and bottomed at -$2000.0 in Q2 2025.